EGLN1 and osteonecrosis: Therefore, based on this scientific background, we speculate that the oxidative damage associated with glucocorticoid-induced osteonecrosis may be related to the ROS/PHD2/HIF-1α signaling pathway, and intervention in this signaling pathway may help to delay the progression of osteonecrosis.